- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.01. | GlucoTrack Shares Slide 25% Despite New Patent Awards | - | RTTNews | ||
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 29.01. | Glucotrack picks up new patents for continuous blood glucose monitor | 1 | MassDevice | ||
| 29.01. | Glucotrack Stumbles Despite Winning Patent | - | Baystreet.ca | ||
| 29.01. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.01. | Glucotrack, Inc.: Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform | 168 | GlobeNewswire (Europe) | RUTHERFORD, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.("Glucotrack", or the "Company") (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization... ► Artikel lesen | |
| 30.12.25 | Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor | 1 | GlobeNewswire (USA) | ||
| 29.12.25 | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.25 | Glucotrack GAAP EPS of -$4.64 | 1 | Seeking Alpha | ||
| 13.11.25 | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.25 | Glucotrack, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11.25 | Glucotrack sagt außerordentliche Hauptversammlung mangels Quorum ab | 2 | Investing.com Deutsch | ||
| 06.11.25 | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.10.25 | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.10.25 | Glucotrack, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 29.09.25 | GlucoTrack files to sell 20.06M shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
| 29.09.25 | Glucotrack, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 15.09.25 | GlucoTrack stock tumbles after issuing $3.6M convertible note | 2 | Investing.com | ||
| 11.09.25 | Glucotrack, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 11.09.25 | Glucotrack, Inc.: Glucotrack to Participate in the Q3 Virtual Investor Summit | 3 | GlobeNewswire (USA) | ||
| 05.09.25 | Glucotrack, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,420 | +1,65 % | EQS-AFR: Eckert & Ziegler SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Eckert & Ziegler SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Eckert & Ziegler SE: Vorabbekanntmachung... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,082 | -4,68 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Warrant Amendments | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - February 20, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("the Company"), a leading regenerative medicine company... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,017 | -6,59 % | NuGen Medical Devices Inc.: NuGen Medical Devices Inc. Provides Update on Health Canada License | Toronto, Ontario--(Newsfile Corp. - February 5, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") is initiating a temporary halt on its devices in Canada due to the lapse... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| UNIDOC HEALTH | 0,066 | 0,00 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results | Revenue increased 22% for the quarter ended December 31, 2025 and 33% for the nine months ended December 31, 2025 compared to prior yearNet loss and net loss per share decreased from prior year for... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,172 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.01.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 22.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.01.2026ISIN NameCA74290F1009 PROBE... ► Artikel lesen | |
| QUIDELORTHO | 19,100 | -1,04 % | QuidelOrtho Corporation: QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio | Agreement adds new analyzer platforms and expands assay menu across key international marketsSAN DIEGO, Feb. 16, 2026 /PRNewswire/ -- QuidelOrtho has entered a long-term strategic supply... ► Artikel lesen | |
| VERU | 2,560 | -4,48 % | Veru Inc.: Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress | -- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter- --Company to host conference call and webcast... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 177,65 | -0,95 % | Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer | Veteran M&A and transformation leader from Danaher and Patheon joins the Quest Diagnostics executive team SECAUCUS, N.J., Feb. 26, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a... ► Artikel lesen | |
| LIFEWARD | 7,400 | +14,37 % | Lifeward Ltd.: Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors | IP and technology acquisition is expected to be highly accretive and to advance Lifeward's position as a diversified biomedical innovation companyWill Expand Lifeward's portfolio beyond lower-limb... ► Artikel lesen | |
| SENSEONICS | 6,900 | -1,43 % | Senseonics Q4 2025 Earnings Preview | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026 | 100% complete response (CR) rate among all six efficacy evaluable patientsFavorable safety profile with no Grade - 3 CRS or ICANSPrior investigator-initiated trial (IIT) reached median progression... ► Artikel lesen | |
| RADNET | 60,50 | +1,68 % | RadNet, Inc.: DeepHealth Achieves CE Mark for TechLive and Enables AWS Marketplace Deployment, Advancing Global Expansion of Multimodality Vendor-Agnostic Remote Scanning Solution |
GLUCOTRACK INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,570 Euro und damit -3,09 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.